Figure 2.
NP incorporation with multiple modalities to target inflammation in IBD. (A) Thermo-sensitive hydrogels, (B) Microneedle-based delivery systems, (C) Ultrasound-assisted drug delivery, and (D) Cellular components derived from human immune cells mimicking endogenous inflammation-targeting mechanisms. These systems in combination with NPs have the potential to further augment the targeting effect of NPs to the site of inflammation, thereby improving efficacy in IBD treatment.